Tg(Thy1-APPSweAut)A7Tiwa
Transgene Detail
|
Symbol: |
Tg(Thy1-APPSweAut)A7Tiwa |
Name: |
transgene insertion A7, Takeshi Iwatsubo |
MGI ID: |
MGI:5559448 |
Synonyms: |
A7 APP Tg, Tg(Thy1-APP*K670N*M671L*T714I)A7Tiwa, Tg(Thy1-APP*Swe*Aut)A7Tiwa |
Transgene: |
Tg(Thy1-APPSweAut)A7Tiwa Location: unknown
|
Alliance: |
Tg(Thy1-APPSweAut)A7Tiwa page
|
|
Strain of Origin: |
Not Specified
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Thy1-APPSweAut)A7Tiwa expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APP (351) |
|
The gene encodes for the Swedish and Austrian mutations. |
|
|
|
Mutation details: This transgene expresses the human APP695 harboring the Swedish K670N and M671L (Swe) and the Austrian T714I (Aut) familial Alzheimer disease mutations in neurons under the control of the Thy1.2 promoter. Immunoblotting shows that expression of transgenic human APP proteins is about 1.4 fold that of endogenous murine App.
(J:204270)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:204270 Yamada K, et al., Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta. J Neurosci. 2009 Sep 9;29(36):11393-8 |
All: |
7 reference(s) |
|